ArticleAnalytical science advances2025
Early Diagnosis of Acute Kidney Injury in Liver Transplant Patients by an Untargeted Metabolomic Approach.
Article in Analytical science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute kidney injury is a common complication in patients undergoing orthotopic liver transplantation, being associated with increased mortality and prolonged hospitalization. This study aimed to develop a novel analytical strategy for the early diagnosis of acute kidney injury in liver transplant recipients by combining an untargeted metabolomic approach with advanced chemometric techniques. Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry coupled with partial least squares discriminant analysis, we successfully classified patient samples according to the severity of renal dysfunction. This integration of high-resolution mass spectrometry with multivariate analysis offers a minimally invasive, cost-effective and precise diagnostic method, requiring only a single serum sample per analysis. The study analysed 132 serum samples from 59 patients at three postoperative time points (0-6 h, 24 h and 48 h). The mass spectra revealed distinct metabolic profiles across different stages of acute kidney injury, highlighting biochemical shifts related to oxidative stress, inflammation and impaired renal function. The discriminant models demonstrated high sensitivity (80%-98%) and specificity (80%-97%), especially in distinguishing advanced stages of kidney injury, where metabolic alterations were most evident. These results support the use of this analytical workflow as a promising tool for early detection and monitoring of acute kidney injury, representing a significant advance in the application of untargeted metabolomics to clinical diagnostics. This work lays the foundation for future clinical translation of metabolomics-based diagnostics in liver transplantation, enabling more effective and timely therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.